On October 17, 2022, HHSC will open all eleven Texas Public Health Service regions to Palivizumab (Synagis) prophylaxis for the 2022-23 Respiratory Syncytial Virus (RSV) season. The 2022-23 RSV season is considered a new season, separate from the summer season, which ends on October 16, 2022.
This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202
